Back to search

University of Thessaly (UTH)

Συνδυασμός ρανολαζίνης - αμιωδαρόνης έναντι αμιωδαρόνης στο χρόνο ανάταξης της πρωτοεμφανισθείσας (new-onset) ή παροξυσμικής κολπικής μαρμαρυγής και εκτίμηση λειτουργικής συμπεριφοράς του αριστερού κόλπου

Abstract

dc:description

Atrial fibrillation (AF) is the most common supraventricular tachyarrhythmia, which has been associated with increased risk forstroke, reduced quality of life, and frequent hospital admissions. Management strategies of patients afflicted with recurrent AF typically include pharmacologic conversion to sinus rhythm, ventricular rate control, electrical cardioversion, or catheter ablation techniques in casesdrug-resistant episodes. Among medications used for the management of this arrhythmia, Amiodarone remains the first-line drug for conversion of recurrent AF paroxysms, however most commonly with significant delay. This is why we have chosen a combination therapy of amiodarone with ranolazine, a new antianginal agent, with strong atrial-selective inhibitory effect of Late Na+ channel, with a view to evaluate the conversion time and the conversion rate of AF. We have also planned to compare the function of the left atrium for patients that have received the combination therapy ofranolazine-amiodarone versus the patients who have received only amiodarone. To establish the role of this combination therapy, we enrolled 173 consecutive patients with paroxysmal AF. The patients were divided into two groups regarding the therapeutic scheme they have received for cardioversion, with 1:1 distribution ratio. Patients were randomized to amiodarone (n = 81), or amiodarone plus ranolazine (n =92). The amiodarone-ranolazine group compared with the amiodarone only group showed significantly shorter time to conversion (10.8 hours earlier) and higher conversion rate at 24 hours (92% vs 58%, p<0.001). From the two groups, 85 patients (41 received amiodarone and 44 received amiodarone-ranolazine) which have been cardioverted to sinus rhythm, were investigated with echocardiogram to assess left atrial function. The two parameters that we have assessed were, LAEF (Left Atrial Ejection Force) and LAKE (Left atrial kinetic energy). Measurements took place at 6 hours post cardioversion and subsequently at 24 and 48 hours. Measurements showed significant superiority on thecombination therapy group immediately at the first 6 hours post AF cardioversion to sinus rhythm. These parameters showed progressive increase at the 24 and 48 hours in both groups in proportion to the initial values. In conclusion, our data suggest that the combination therapy (amiodarone-ranolazine) was superior to a single therapy (amiodarone) regarding the time to conversion and the conversion rate of paroxysmal AF. Also, when ranolazine was combined with amiodarone it achieved significant increase of LAEF and LAKE parameters. This indicates significant improvement of left atrial systolic function post AF cardioversion.

Degree

thesis:*
Grantor dc:publisher
University of Thessaly (UTH)
Year dc:date
2020

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Tsanaxidis, Nikolaos
  • Τσαναξίδης, Νικόλαος

Subjects

dc:subject × 12

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/47071

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Tsanaxidis, Nikolaos; Τσαναξίδης, Νικόλαος. Συνδυασμός ρανολαζίνης - αμιωδαρόνης έναντι αμιωδαρόνης στο χρόνο ανάταξης της πρωτοεμφανισθείσας (new-onset) ή παροξυσμικής κολπικής μαρμαρυγής και εκτίμηση λειτουργικής συμπεριφοράς του αριστερού κόλπου. University of Thessaly (UTH), 2020. http://hdl.handle.net/10442/hedi/47071